RegisterLogin

Nilotinib-d3

CAT: 0804-HY-132549SSize: 1 mgDry Ice: NoHazardous: No
CAT#: HY-132549SSize: 1 mg
Selected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Nilotinib-d3 is the deuterium labeled Nilotinib. Nilotinib is an orally available Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity[1][2].
CAS Number
[1215678-43-5]
UNSPSC
12352005
Target
Autophagy; Bcr-Abl; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Autophagy; Others; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Solubility
10 mM in DMSO
Smiles
C(F)(F)(F)C=1C=C(C=C(NC(=O)C2=CC(NC=3N=C(C=CN3)C=4C=CC=NC4)=C(C)C=C2)C1)N5C=NC(C([2H])([2H])[2H])=C5
Molecular Formula
C28H19D3F3N7O
Molecular Weight
532.53
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Weisberg E, et al. Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias. Blood. 2007 Mar 1;109 (5) :2112-20.|[3]Sako H, et al. Antitumor effect of the tyrosine kinase inhibitor Nilotinib on gastrointestinal stromal tumor (GIST) and Imatinib-resistant GIST cells. PLoS One. 2014 Sep 15;9 (9) :e107613.|[4]Dervis Hakim G, et al. Mucosal healing effect of nilotinib in indomethacin-induced enterocolitis: A rat model. World J Gastroenterol. 2015 Nov 28;21 (44) :12576-85.|[5]Fujita KI, et al. Involvement of the Transporters P-Glycoprotein and Breast Cancer Resistance Protein in Dermal Distribution of the Multikinase Inhibitor Regorafenib and Its Active Metabolites. J Pharm Sci. 2017 Sep;106 (9) :2632-2641.|[6]Meirson T, et al. Targeting invadopodia-mediated breast cancer metastasis by using ABL kinase inhibitors. Oncotarget. 2018 Apr 24;9 (31) :22158-22183.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-10159S1Nilotinib-13C, d3
HY-10159-01Nilotinib
HY-135637Nilotinib Acid
HY-10159BNilotinib (hydrochloride)
HY-10159R-01Nilotinib (Standard)
HY-10159S-01Nilotinib-d6
HY-10159A-01Nilotinib (monohydrochloride monohydrate)
HY-10159C-01Nilotinib (hydrochloride dihydrate)
HY-10159AR-01Nilotinib (monohydrochloride monohydrate) (Standard)
HY-15398S3-01Vitamin D3-d3

Alternative Products

CatalogName
018138Nilotinib-d3
MBS6022531-01Nilotinib-d3
TRC-N465302-1MGNilotinib-d3
TRC-N465302-10MGNilotinib-d3
sc-219376Nilotinib-d3
MBS808163-01Nilotinib
T1524-01Nilotinib
GP5854-500mgNilotinib
TRC-N465300-500MGNilotinib
SIH-463-25MGNilotinib

Popular Products